Long acting opioid dependence treatments are preferred by patients

Embargoed until: Publicly released: 2021-05-11 01:00

Australia; NSW; VIC

Patients being treated for opioid dependencies prefer longer-acting versions of the drug buprenorphine that can be given as weekly or monthly injections to other forms that need to be taken every day, according to Australian research. The clinical trial of 119 participants, reported that treatment satisfaction was higher in the group receiving weekly or monthly buprenorphine than in
the group receiving daily buprenorphine at six months.

Media release

From:

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research JAMA, Web page Please link to the article in online versions of your report (the URL will go live after the embargo ends).

Journal/
conference: JAMA Network Open

Research:Paper

Organisation/s: The University of Sydney, The University of Newcastle, Monash University, The University of New South Wales, South Eastern Sydney Local Health District, Camurus, Sweden

Funder: This study was supported by Camurus AB.

Media Contact/s

Contact details are only visible to registered journalists.